On July 1, 2020, Dongguan Nabai Medical Technology Co., LTD. (hereinafter referred to as "Nabai Medical"), a leading CDMO enterprise focusing on the high-quality medical device industry in China, announced that Naba Medical Had received a strategic investment of 100 million YUAN from Yunfeng Fund.
Nabai Medical was founded in 2010, the company currently has three production bases, the factory area of 46,000 square meters.The best medical provides professional medical devices industry design, research and development, optimization, hand custom, mold design and manufacturing, injection molding, precision sheet metal machining and assembly foundry production services such as medical devices, covering medical instrument precision components all chain upstream r&d, manufacturing, OEM, is a domestic coverage of big small and medium-sized medical equipment structure of whole process CDMO model supplier, provide more than 500 enterprises with precision delicate, security and stability of products and services, with a number of well-known enterprises at home and abroad to establish long-term, stable relations of cooperation,Such as Mindray Medical, Dedray Medical, Mike Biological, New Industry Biological, Wandong Medical, Yuyue medical, Comtech, Redu Life, Open Medical, Pegatron Biological, Shengxiang Biological, etc.
Yunfeng Fund was founded in 2010 by Jack Ma, founder of Alibaba Group, and Yu Feng, founder of Mass Media, together with a group of industry leaders and successful entrepreneurs.At the beginning of the establishment, the most important gene of Yunfeng Fund is entrepreneurship.In addition to the investment, Yunfeng Fund is committed to helping invested enterprises to better develop in terms of development strategy, organization management, brand building, etc., and to pay attention to and achieve future-oriented industry leaders.
Yunfeng capital executive director Dr Huang Xiao said: "China's huge medical market contains the huge potential of technology innovation and efficiency, which is focus on investment opportunities in the field of medical technology and manufacturing, hope will have investment of medical apparatus and instruments, innovative medicine, IVD detection, medical service resources together to form organic ecological enterprises and institutions.Nabi Medical is one of the few domestic enterprises with the strength of CDMO in the whole industry chain of medical devices. It has the capability of r&d, production optimization and final assembly of the full ecological chain of precise components of medical devices and IVD equipment."We believe nabel will drive the continued transformation of the traditional medical device market in a way that is driven by technology and process optimization.
Front row from left: Mr. Huang Xin, partner of Yunfeng Fund, And Mr. Wang Gennian, chairman of Nabai Medical
Back row, from left: Mr. Yu Feng, chairman of Yunfeng Fund, And Dr. Ye Xiaoping, chairman of Taige Medical
Mr. Wang Geng, chairman of Nabai Medical, said: This financing will provide customers with better all-round personal service experience and one-stop solution, expand the scale of production and operation, alleviate the pressure of production capacity in short supply and meet the requirements of timely delivery of orders, and further implement the long-term planning of the whole CDMO industry chain of the company.
Future the best medical division will adhere to the business and customer service localization principle of timely response, work closely with customers to solve late in the middle of the early research and development design, manufacturing and testing different problems such as link, meet "many varieties, small batch, high demand" industry demand characteristic, and introduce all kinds of hi-tech talents and upgrade intelligent equipment, will build a nationwide in south China, north China, east China and southwest China production base form a pattern of "SanZhu a" market services.
